Results 241 to 250 of about 3,164,915 (295)

CEACAM1 participation in breast cancer progression

open access: yesMolecular Oncology, EarlyView.
In invasive breast cancer (BC), CEACAM1 shifts from an apical to a uniform membranous/cytoplasmic pattern, or is lost, as tumors dedifferentiate, inversely tracking the Ki‐67 proliferative index. In MCF‐7 cells, only CEACAM1‐4L suppresses proliferation, repressing cell cycle and growth factor genes.
Mykola Lyndin   +3 more
wiley   +1 more source

Pharmacological chromatin remodeling enhances response to estrogen therapy in ER+ breast cancer

open access: yesMolecular Oncology, EarlyView.
Estrogen therapy elicits clinical benefit in ~ 30% of patients with endocrine‐resistant estrogen receptor (ER)‐positive breast cancer. Based on findings that ER transcriptional activation underlies response to estrogen therapy, we tested the effects of epigenetic dysregulation via pharmacological inhibition of histone deacetylases (HDACi).
Anneka L. Johnson Thomas   +16 more
wiley   +1 more source

Climate drivers of historic tree growth in the Vienna Woods and prediction of future performance of eight selected tree species. [PDF]

open access: yesFor Ecol Manage
Dolschak K   +10 more
europepmc   +1 more source

Efficacy of an Herbal Cream on Patients with Hemorrhoids: a randomized triple-blind controlled trial. [PDF]

open access: yesJ Pharmacopuncture
Zohalinezhad ME   +11 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy